Literature DB >> 26341428

Pure Endoscopic Endonasal Transsphenoidal Approach for Nonfunctioning Pituitary Adenomas in the Elderly: Surgical Outcomes and Complications in 158 Patients.

Rucai Zhan1, Zhenshen Ma2, Donghai Wang3, Xingang Li4.   

Abstract

OBJECTIVE: To evaluate the safety and efficacy of the endoscopic endonasal transsphenoidal approach (EETA) for nonfunctioning pituitary adenoma (NFPA) in the elderly population.
METHODS: We performed a retrospective review of operative cases over a 7-year period, in which 158 elderly patients (age 65 years and older) who underwent a pure EETA to remove a pituitary adenoma were identified and compared with a series of 155 younger patients (age 40-55 years) who underwent the same procedure during the same period. The medical charts of the patients were reviewed to collect demographic information, such as age, sex, clinical symptoms, tumor size, the extent of tumor resection, clinical outcome, and complications.
RESULTS: In the elderly group, total resection was achieved in 120 patients (75.9%), and 124 patients (78.5%) achieved significant postsurgical visual remission. In the younger group, total resection was achieved in 119 patients (76.8%), with 126 patients (81.2%) achieving significant postsurgical visual remission. Regarding surgical complications in the elderly group, transient diabetes insipidus occurred postoperatively in 28 (17.8%) patients, and permanent diabetes insipidus occurred in 7 (4.4%) patients. Six (6.4%) patients experienced postoperative cerebrospinal fluid leakage, and new developments of anterior hypopituitarism occurred in 15 (9.5%) cases. In the younger group, 21 (13.6%) patients developed transient diabetes insipidus postoperatively, and 5 (3.2%) patients experienced permanent diabetes insipidus. Six (3.9%) patients reported postoperative cerebrospinal fluid leaks, and 13 (8.4%) patients developed a new anterior hypopituitarism. There were no cases of either carotid artery injury or death in either group. During the follow-up (mean, 32 months), 11 (6.9%) patients experienced tumor recurrence in the elderly group compared with 24 (15.5%) patients in the younger group. Of the 15 elderly patients who developed new hypopituitarism, 13 (86.7%) recovered without hormone replacement; accordingly, the rate of hypopituitarism remission was 84.6% in the younger patients.
CONCLUSIONS: NFPAs in the elderly can be resected via a pure endoscopic technique with low morbidity and mortality.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complications; Elderly patients; Endoscopic endonasal transsphenoidal approach; Nonfunctioning pituitary adenoma; Surgical outcome

Mesh:

Year:  2015        PMID: 26341428     DOI: 10.1016/j.wneu.2015.08.035

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  20 in total

Review 1.  Gross total resection of pituitary adenomas after endoscopic vs. microscopic transsphenoidal surgery: a meta-analysis.

Authors:  Reem D Almutairi; Ivo S Muskens; David J Cote; Mark D Dijkman; Vasileios K Kavouridis; Erin Crocker; Kholoud Ghazawi; Marike L D Broekman; Timothy R Smith; Rania A Mekary; Hasan A Zaidi
Journal:  Acta Neurochir (Wien)       Date:  2018-01-06       Impact factor: 2.216

2.  Pituitary adenomas in elderly patients: clinical and surgical outcome analysis in a large series.

Authors:  Alfio Spina; Marco Losa; Pietro Mortini
Journal:  Endocrine       Date:  2019-06-17       Impact factor: 3.633

3.  Endoscopic transsphenoidal surgery for biochemically and clinically non-functioning adenohypophyseal tumours in the elderly: experience from a single UK centre.

Authors:  Boon Leong Quah; Andrew Edwards-Bailey; Kanna Gnanalingham; Omar Pathmanaban; Hariclea Vasilopoulos; Federico Roncaroli; Tara Kearney; James Balogun; Konstantina Karabatsou
Journal:  Endocrine       Date:  2021-11-05       Impact factor: 3.633

4.  Cerebrospinal Fluid Leak after Transsphenoidal Surgery: A Systematic Review and Meta-analysis.

Authors:  Emma M H Slot; Rengin Sabaoglu; Eduard H J Voormolen; Eelco W Hoving; Tristan P C van Doormaal
Journal:  J Neurol Surg B Skull Base       Date:  2021-08-20

5.  Surgical Outcomes of Endoscopic Transsphenoidal Pituitary Adenoma Resection in Elderly Versus Younger Patients.

Authors:  Tyler D Alexander; Chandala Chitguppi; Sarah Collopy; Kira Murphy; Pascal Lavergne; Prachi Patel; Tawfiq Khoury; Mindy Rabinowitz; Gurston G Nyquist; Marc R Rosen; Christopher J Farrell; Michael Karsy; James J Evans
Journal:  J Neurol Surg B Skull Base       Date:  2022-01-31

6.  Surgical Experience in Prevention of Postoperative CSF Leaks Using Abdominal Fat Grafts in Endoscopic Endonasal Transsphenoidal Surgery for Pituitary Adenomas.

Authors:  Stephen Ahn; Jae-Sung Park; Do H Kim; Sung W Kim; Sin-Soo Jeun
Journal:  J Neurol Surg B Skull Base       Date:  2020-08-20

7.  Assessing Risk of Severe Complications after Endoscopic Transnasal Transsphenoidal Surgery: A Comparison of Frailty, American Society of Anesthesiologists, and Comorbidity Scores.

Authors:  Jordan M Sukys; Roy Jiang; Richard P Manes
Journal:  J Neurol Surg B Skull Base       Date:  2021-12-16

8.  Transsphenoidal Surgery of Giant Pituitary Adenoma: Results and Experience of 239 Cases in A Single Center.

Authors:  Yike Chen; Xiaohui Xu; Jing Cao; Yuanqing Jie; Linkai Wang; Feng Cai; Sheng Chen; Wei Yan; Yuan Hong; Jianmin Zhang; Qun Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-06       Impact factor: 6.055

9.  Surgical management of pituitary adenomas: does age matter?

Authors:  Valentina Tardivo; Federica Penner; Diego Garbossa; Giuseppe Di Perna; Paolo Pacca; Luca Salvati; Roberto Altieri; Silvia Grottoli; Francesco Zenga
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

10.  Impact of age on postsurgical outcomes of nonfunctioning pituitary adenomas.

Authors:  E Biamonte; N Betella; D Milani; G B Lasio; S Ariano; S Radice; E Lavezzi; G Mazziotti; A Lania
Journal:  Endocrine       Date:  2020-11-26       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.